Heart failure and the heart-brain axis

Wolfram Doehner1,2,3, Jelena Čelutkienė4,5,6, Mehmet Birhan Yilmaz7

  • 1Center for Stroke Research Berlin (CSB), Charité Universitätsmedizin Berlin, Berlin, Germany.

Insights

Heart failure (HF) significantly impacts the central nervous system (CNS), causing stroke, cognitive decline, and depression. These brain issues worsen HF, highlighting the need for better diagnosis and treatment of this cardiac-cerebral interaction.

Area of Science:

  • Cardiology
  • Neurology
  • Neuroscience

Background:

  • Heart failure (HF) involves complex interactions between the heart and central nervous system (CNS).
  • These interactions can lead to mutual functional impairment, affecting both cardiac and cerebral health.
  • The clinical significance of this cardiac-cerebral comorbidity is often under-recognized in diagnosis and treatment.

Purpose of the Study:

  • To discuss the pathophysiologic aspects of heart-CNS interactions in HF.
  • To examine the impact of HF on cerebral functions, including stroke, cognitive decline, and depression.
  • To review current treatment options for cerebral dysfunction in HF patients.

Main Methods:

  • Review of existing literature on heart-CNS interactions in heart failure.
  • Discussion of neurophysiological and neurochemical mechanisms involved.
  • Analysis of clinical implications and treatment strategies.

Main Results:

  • HF can cause cerebral injuries like stroke, cognitive impairment, and depression.
  • Impaired brain function can exacerbate myocardial injury and HF progression.
  • Brainstem functions, neurohormonal control, and cardiovascular reflexes are implicated in HF's cardiac-cerebral dialogue.

Conclusions:

  • The interplay between the heart and CNS is critical in HF pathophysiology.
  • Cerebral complications significantly impact HF severity, progression, and mortality.
  • Integrated diagnostic and therapeutic approaches are needed to address cardiac-cerebral interactions in HF.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
20
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
24